Survivorship in a population based cohort of patients with Sjogren's syndrome, 1976-1992

Peter B. Martens, Stanley R. Pillemer, Lennert T H Jacobsson, W. Michael O'Fallon, Eric Lawrence Matteson

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Objective. Sjogren's syndrome (SS) has been associated with development of lymphoid malignancies and other significant medical complications, but the effect of SS on survival in a population based sample has not been reported. We analyzed survival in an incidence cohort of patients diagnosed with SS in residents of Olmsted County, Minnesota, USA, between 1976 and 1992. Methods. All records of physician diagnosed SS were reviewed, as well as all records from patients diagnosed with xerostomia and keratoconjunctivitis sicca, and records of patients with rheumatoid arthritis (RA) and systemic lupus erythematosus. The case definition for SS required 2 of 3 criteria: keratoconjunctivitis sicca, xerostomia, or serologic abnormality. Confounding illnesses were excluded. All patients were white. Results. Of the 74 cases of SS identified, 50 (67%) had primary SS and 24 (33%) secondary SS. An average of 7.2 years of followup was available for patients with primary SS and 9.9 years for patients with secondary SS. Compared with the general population, patients with SS had increased mortality (p = 0.04). When patients with primary and secondary SS were studied separately, increased mortality was found in patients with secondary SS (p < 0.005) but not primary SS (p = 0.86). Conclusion. In this population based cohort, patients with primary SS did not have increased mortality. However, mortality may have been increased in patients with secondary SS, the majority of whom had RA.

Original languageEnglish (US)
Pages (from-to)1296-1300
Number of pages5
JournalJournal of Rheumatology
Volume26
Issue number6
StatePublished - 1999

Fingerprint

Sjogren's Syndrome
Survival Rate
Population
Keratoconjunctivitis Sicca
Xerostomia
Mortality
Rheumatoid Arthritis
Survival
Systemic Lupus Erythematosus

Keywords

  • Epidemiology
  • Mortality
  • Sjogren's syndrome

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

Martens, P. B., Pillemer, S. R., Jacobsson, L. T. H., O'Fallon, W. M., & Matteson, E. L. (1999). Survivorship in a population based cohort of patients with Sjogren's syndrome, 1976-1992. Journal of Rheumatology, 26(6), 1296-1300.

Survivorship in a population based cohort of patients with Sjogren's syndrome, 1976-1992. / Martens, Peter B.; Pillemer, Stanley R.; Jacobsson, Lennert T H; O'Fallon, W. Michael; Matteson, Eric Lawrence.

In: Journal of Rheumatology, Vol. 26, No. 6, 1999, p. 1296-1300.

Research output: Contribution to journalArticle

Martens, PB, Pillemer, SR, Jacobsson, LTH, O'Fallon, WM & Matteson, EL 1999, 'Survivorship in a population based cohort of patients with Sjogren's syndrome, 1976-1992', Journal of Rheumatology, vol. 26, no. 6, pp. 1296-1300.
Martens, Peter B. ; Pillemer, Stanley R. ; Jacobsson, Lennert T H ; O'Fallon, W. Michael ; Matteson, Eric Lawrence. / Survivorship in a population based cohort of patients with Sjogren's syndrome, 1976-1992. In: Journal of Rheumatology. 1999 ; Vol. 26, No. 6. pp. 1296-1300.
@article{02f31cced29d4235b8dc725e17b60e3d,
title = "Survivorship in a population based cohort of patients with Sjogren's syndrome, 1976-1992",
abstract = "Objective. Sjogren's syndrome (SS) has been associated with development of lymphoid malignancies and other significant medical complications, but the effect of SS on survival in a population based sample has not been reported. We analyzed survival in an incidence cohort of patients diagnosed with SS in residents of Olmsted County, Minnesota, USA, between 1976 and 1992. Methods. All records of physician diagnosed SS were reviewed, as well as all records from patients diagnosed with xerostomia and keratoconjunctivitis sicca, and records of patients with rheumatoid arthritis (RA) and systemic lupus erythematosus. The case definition for SS required 2 of 3 criteria: keratoconjunctivitis sicca, xerostomia, or serologic abnormality. Confounding illnesses were excluded. All patients were white. Results. Of the 74 cases of SS identified, 50 (67{\%}) had primary SS and 24 (33{\%}) secondary SS. An average of 7.2 years of followup was available for patients with primary SS and 9.9 years for patients with secondary SS. Compared with the general population, patients with SS had increased mortality (p = 0.04). When patients with primary and secondary SS were studied separately, increased mortality was found in patients with secondary SS (p < 0.005) but not primary SS (p = 0.86). Conclusion. In this population based cohort, patients with primary SS did not have increased mortality. However, mortality may have been increased in patients with secondary SS, the majority of whom had RA.",
keywords = "Epidemiology, Mortality, Sjogren's syndrome",
author = "Martens, {Peter B.} and Pillemer, {Stanley R.} and Jacobsson, {Lennert T H} and O'Fallon, {W. Michael} and Matteson, {Eric Lawrence}",
year = "1999",
language = "English (US)",
volume = "26",
pages = "1296--1300",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "6",

}

TY - JOUR

T1 - Survivorship in a population based cohort of patients with Sjogren's syndrome, 1976-1992

AU - Martens, Peter B.

AU - Pillemer, Stanley R.

AU - Jacobsson, Lennert T H

AU - O'Fallon, W. Michael

AU - Matteson, Eric Lawrence

PY - 1999

Y1 - 1999

N2 - Objective. Sjogren's syndrome (SS) has been associated with development of lymphoid malignancies and other significant medical complications, but the effect of SS on survival in a population based sample has not been reported. We analyzed survival in an incidence cohort of patients diagnosed with SS in residents of Olmsted County, Minnesota, USA, between 1976 and 1992. Methods. All records of physician diagnosed SS were reviewed, as well as all records from patients diagnosed with xerostomia and keratoconjunctivitis sicca, and records of patients with rheumatoid arthritis (RA) and systemic lupus erythematosus. The case definition for SS required 2 of 3 criteria: keratoconjunctivitis sicca, xerostomia, or serologic abnormality. Confounding illnesses were excluded. All patients were white. Results. Of the 74 cases of SS identified, 50 (67%) had primary SS and 24 (33%) secondary SS. An average of 7.2 years of followup was available for patients with primary SS and 9.9 years for patients with secondary SS. Compared with the general population, patients with SS had increased mortality (p = 0.04). When patients with primary and secondary SS were studied separately, increased mortality was found in patients with secondary SS (p < 0.005) but not primary SS (p = 0.86). Conclusion. In this population based cohort, patients with primary SS did not have increased mortality. However, mortality may have been increased in patients with secondary SS, the majority of whom had RA.

AB - Objective. Sjogren's syndrome (SS) has been associated with development of lymphoid malignancies and other significant medical complications, but the effect of SS on survival in a population based sample has not been reported. We analyzed survival in an incidence cohort of patients diagnosed with SS in residents of Olmsted County, Minnesota, USA, between 1976 and 1992. Methods. All records of physician diagnosed SS were reviewed, as well as all records from patients diagnosed with xerostomia and keratoconjunctivitis sicca, and records of patients with rheumatoid arthritis (RA) and systemic lupus erythematosus. The case definition for SS required 2 of 3 criteria: keratoconjunctivitis sicca, xerostomia, or serologic abnormality. Confounding illnesses were excluded. All patients were white. Results. Of the 74 cases of SS identified, 50 (67%) had primary SS and 24 (33%) secondary SS. An average of 7.2 years of followup was available for patients with primary SS and 9.9 years for patients with secondary SS. Compared with the general population, patients with SS had increased mortality (p = 0.04). When patients with primary and secondary SS were studied separately, increased mortality was found in patients with secondary SS (p < 0.005) but not primary SS (p = 0.86). Conclusion. In this population based cohort, patients with primary SS did not have increased mortality. However, mortality may have been increased in patients with secondary SS, the majority of whom had RA.

KW - Epidemiology

KW - Mortality

KW - Sjogren's syndrome

UR - http://www.scopus.com/inward/record.url?scp=0032995905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032995905&partnerID=8YFLogxK

M3 - Article

C2 - 10381046

AN - SCOPUS:0032995905

VL - 26

SP - 1296

EP - 1300

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 6

ER -